Evidence map›Paper›PMID 34849409›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2021

Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting.

Kevin Montes, Himachandana Atluri, Hibeb Silvestre Tuch, Lucrecia Ramirez, Juan Paiz, Ana Hesse Lopez, Thomas C Bailey, Andrej Spec, Carlos Mejia-Chew

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Case reports in nephrology · 2025
    Article
  3. Article
  4. Undiagnosed and missed active pulmonary tuberculosis during mass gatherings: a prospective cross-sectional study from the Hajj pilgrimage.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kevin MontesDepartment of Medicine, Washington University School of Medicine in St. Louis, USA.
Himachandana AtluriDepartment of Medicine, Washington University School of Medicine in St. Louis, USA.
Hibeb Silvestre TuchTuberculosis Program, Ministry of Public Health and Social Assistance, Guatemala City, Guatemala.
Lucrecia RamirezTuberculosis Program, Ministry of Public Health and Social Assistance, Guatemala City, Guatemala.
Juan PaizTuberculosis Program, Ministry of Public Health and Social Assistance, Guatemala City, Guatemala.
Ana Hesse LopezTuberculosis Program, Ministry of Public Health and Social Assistance, Guatemala City, Guatemala.
Thomas C BaileyDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, USA.
Andrej SpecDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, USA.
Carlos Mejia-ChewDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, USA.
Washington University in St. Louis · USMinistry of Public Health and Social Assistance · GT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisk factors for mortality and MDR-TB in Guatemala are poorly understood. We aimed to identify risk factors to assist in targeting public health interventions.

methodsWe performed a retrospective study of adults with pulmonary TB reported to the Guatemalan TB Program between January 1, 2016 and December 31, 2017. The primary objective was to determine risk factors for mortality in pulmonary TB. The secondary objective was to determine risk factors associated with MDR-TB.

resultsAmong 3,945 patients with pulmonary TB, median age was 39 years (IQR 25-54), 59% were male, 25% of indigenous ethnicity, 1.1% had MDR-TB and 3.9% died. On multivariable analysis, previous TB treatment (odds ratio [OR] 3.57, CI 2.24-5.68 [p < 0.001]), living with HIV (OR 3.98, CI 2.4-6.17 [p < 0.001]), unknown HIV diagnosis (OR 2.65, CI 1.68-4.18 [p < 0.001]), indigenous ethnicity (OR 1.79, CI 1.18-2.7 [p = 0.005]), malnutrition (OR 7.33, CI 3.24-16.59 [p < 0.001]), and lower educational attainment (OR 2.86, CI 1.43-5.88 [p = 0.003]) were associated with mortality. Prior treatment (OR 53.76, CI 25.04-115.43 [p < 0.001]), diabetes (OR 4.13, CI 2.04-8.35 [p < 0.001]), and indigenous ethnicity (OR 11.83, CI 1.46-95.73 [p = 0.02]) were associated with MDR-TB.

conclusionsIn Guatemala, both previous TB treatment and indigenous ethnicity were associated with higher TB mortality and MDR-TB risk among patients with pulmonary TB.

Indexed as

Central AmericaGuatemalaMDR-TBMortalityRisk factors

Identifiers

PMID34849409
PMCPMC8608588
OpenAlexW3213802809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.